1. Home
  2. DCTH vs FBIZ Comparison

DCTH vs FBIZ Comparison

Compare DCTH & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • FBIZ
  • Stock Information
  • Founded
  • DCTH 1988
  • FBIZ 1909
  • Country
  • DCTH United States
  • FBIZ United States
  • Employees
  • DCTH 76
  • FBIZ N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • FBIZ Major Banks
  • Sector
  • DCTH Health Care
  • FBIZ Finance
  • Exchange
  • DCTH Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • DCTH 426.3M
  • FBIZ 396.0M
  • IPO Year
  • DCTH N/A
  • FBIZ N/A
  • Fundamental
  • Price
  • DCTH $11.52
  • FBIZ $52.84
  • Analyst Decision
  • DCTH Strong Buy
  • FBIZ Strong Buy
  • Analyst Count
  • DCTH 4
  • FBIZ 4
  • Target Price
  • DCTH $24.00
  • FBIZ $56.50
  • AVG Volume (30 Days)
  • DCTH 873.0K
  • FBIZ 60.1K
  • Earning Date
  • DCTH 08-04-2025
  • FBIZ 07-24-2025
  • Dividend Yield
  • DCTH N/A
  • FBIZ 2.16%
  • EPS Growth
  • DCTH N/A
  • FBIZ 26.78
  • EPS
  • DCTH N/A
  • FBIZ 5.48
  • Revenue
  • DCTH $53,850,000.00
  • FBIZ $148,866,000.00
  • Revenue This Year
  • DCTH $155.42
  • FBIZ $18.39
  • Revenue Next Year
  • DCTH $37.93
  • FBIZ $7.81
  • P/E Ratio
  • DCTH N/A
  • FBIZ $9.65
  • Revenue Growth
  • DCTH 1068.87
  • FBIZ 9.38
  • 52 Week Low
  • DCTH $7.17
  • FBIZ $36.26
  • 52 Week High
  • DCTH $18.23
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • FBIZ 61.70
  • Support Level
  • DCTH $12.11
  • FBIZ $52.11
  • Resistance Level
  • DCTH $14.15
  • FBIZ $54.22
  • Average True Range (ATR)
  • DCTH 0.57
  • FBIZ 1.25
  • MACD
  • DCTH -0.16
  • FBIZ 0.28
  • Stochastic Oscillator
  • DCTH 9.67
  • FBIZ 72.76

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: